Unique Ingredient Identifier 5Y0974F5PW is listed as a ingredient substance
| RN | 9004-64-2 |
| RXCUI | 1485045 |
| MF | Polymer substance not supported |
UNII 5Y0974F5PW HYDROXYPROPYL CELLULOSE (110000 WAMW) is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL | FILM | 18.92 MG |
| ORAL | CAPSULE | 0.2 MG |
| ORAL | CAPSULE, DELAYED ACTION | 75 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 25.2 MG |
| ORAL | GRANULE | NA |
| ORAL | POWDER, FOR ORAL SUSPENSION | 25 MG |
| ORAL | SUSPENSION | 16.65 mg/5mL |
| ORAL | TABLET | 30 mg |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 40 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 5 MG |
| ORAL | TABLET, CHEWABLE | 60 MG |
| ORAL | TABLET, DELAYED ACTION | 3.5 MG |
| ORAL | TABLET, DELAYED RELEASE | 8.1 MG |
| ORAL | TABLET, EXTENDED RELEASE | 18 mg |
| ORAL | TABLET, FILM COATED | 92 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 28.7 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 2.25 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 15 mg |